Breaking Barriers with PCR: Innovative Solutions for Clinical Trial Success

PCR technologies are central to clinical acceleration in gene therapy, cell therapy, and oncology development. Join experts from Precision for Medicine, Indaptus Therapeutics and Avidity Biosciences, as they discuss how PCR-based molecular monitoring delivers high-resolution, regulatory-grade data across trial phases.

Designed for translational scientists, clinical developers, and biomarker strategists, this session explores assay design strategies that align with scientific, operational, and regulatory goals to drive therapeutic advancement.

Key takeaways from the session:

• Application of PCR across therapeutic areas and diverse endpoints 

• Strategic use of PCR for early detection, patient stratification, and real-time monitoring in advanced therapy trials

• Designing, validating, and implementing qPCR/ddPCR assays to meet clinical and regulatory goals with optimal sensitivity and efficiency

• First-hand case studies from biotech leaders on leveraging PCR innovation to achieve key milestones in clinical development